Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minjun Chen

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Archives of Toxicology|November 14, 2019
The landscape of hepatobiliary adverse reactions across 53 herbal and dietary supplements reveals immune-mediated injury as a common cause of hepatitisJieqiang Zhu, Minjun Chen, Jürgen Borlak, et al.
Drug Discovery Today|August 13, 2025
New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?Shivangi Shrimali, Minjun Chen, Dongying Li, et al.
Ecotoxicology and Environmental Safety|November 21, 2018
Atmospheric PM<sub>2.5</sub> aspiration causes tauopathy by disturbing the insulin signaling pathwayWei Wei, Minjun Chen, Guangke Li, et al.
Scientific Reports|December 13, 2017
Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved DrugsHuixiao Hong, Shraddha Thakkar, Minjun Chen, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2016
QSAR Models at the US FDA/NCTRHuixiao Hong, Minjun Chen, Hui Wen Ng, et al.
Molecules (Basel, Switzerland)|July 9, 2022
Facile Microfluidic Fabrication of Biocompatible Hydrogel Microspheres in a Novel Microfluidic DeviceMinjun Chen, Ruqaiya Aluunmani, Guido Bolognesi, et al.
International Journal of Environmental Research and Public Health|October 23, 2021
Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver InjuryRoland Moore, Kristin Ashby, Tsung-Jen Liao, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 17, 2022
Integrative approaches for studying the role of noncoding RNAs in influencing drug efficacy and toxicityDongying Li, Minjun Chen, Huixiao Hong, et al.
Diagnostic Microbiology and Infectious Disease|August 23, 2011
The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MICHongbin Chen, Yudong Liu, Wenjia Sun, et al.
Drug Discovery Today|October 4, 2021
A systematic comparison of hepatobiliary adverse drug reactions in FDA and EMA drug labeling reveals discrepanciesYue Wu, Wenzhong Xiao, Weida Tong, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Archives of Toxicology|November 14, 2019
The landscape of hepatobiliary adverse reactions across 53 herbal and dietary supplements reveals immune-mediated injury as a common cause of hepatitisJieqiang Zhu, Minjun Chen, Jürgen Borlak, et al.
Drug Discovery Today|August 13, 2025
New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?Shivangi Shrimali, Minjun Chen, Dongying Li, et al.
Ecotoxicology and Environmental Safety|November 21, 2018
Atmospheric PM<sub>2.5</sub> aspiration causes tauopathy by disturbing the insulin signaling pathwayWei Wei, Minjun Chen, Guangke Li, et al.
Scientific Reports|December 13, 2017
Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved DrugsHuixiao Hong, Shraddha Thakkar, Minjun Chen, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2016
QSAR Models at the US FDA/NCTRHuixiao Hong, Minjun Chen, Hui Wen Ng, et al.
Molecules (Basel, Switzerland)|July 9, 2022
Facile Microfluidic Fabrication of Biocompatible Hydrogel Microspheres in a Novel Microfluidic DeviceMinjun Chen, Ruqaiya Aluunmani, Guido Bolognesi, et al.
International Journal of Environmental Research and Public Health|October 23, 2021
Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver InjuryRoland Moore, Kristin Ashby, Tsung-Jen Liao, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 17, 2022
Integrative approaches for studying the role of noncoding RNAs in influencing drug efficacy and toxicityDongying Li, Minjun Chen, Huixiao Hong, et al.
Diagnostic Microbiology and Infectious Disease|August 23, 2011
The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MICHongbin Chen, Yudong Liu, Wenjia Sun, et al.
Drug Discovery Today|October 4, 2021
A systematic comparison of hepatobiliary adverse drug reactions in FDA and EMA drug labeling reveals discrepanciesYue Wu, Wenzhong Xiao, Weida Tong, et al.
Pageof 14